Skip to content
    Hudson Bay Capital logo

    Hudson Bay Capital

    Greenwich, Connecticut, United StatesFounded 2005

    Hudson Bay Capital Management LP is a multi-billion dollar global multi-strategy investment management firm that targets traditional and non-traditional sources of alpha by employing multiple absolute return strategies and utilizing rigorous fundamental analysis.

    They made 1 investments in the last 12 months. Average disclosed round size is $79.3M (across 7 rounds with reported amounts).

    Find people at Hudson Bay Capital on Goldilocks AI

    Portfolio

    8

    Fund Size

    Top Stage

    Series C

    Last 12 Mo

    1

    Team

    George Antonopoulos

    George Antonopoulos

    Managing Partner & Portfolio Manager

    Roy Astrachan

    Roy Astrachan

    Managing Partner & Portfolio Manager

    Sander R. Gerber

    Sander R. Gerber

    Managing Partner, Chief Executive Officer & Chief Investment Officer

    Yoav Roth

    Yoav Roth

    Managing Partner & Portfolio Manager

    Brendan Albee

    Brendan Albee

    Partner, Chief Operating Officer

    Juliette Cottrill

    Juliette Cottrill

    Partner, Head of Investor Relations & Business Development

    Luka Djunic

    Luka Djunic

    Partner & Portfolio Manager

    Mark Willis

    Mark Willis

    Partner, Treasurer & General Counsel

    Mousmi Sharma

    Mousmi Sharma

    Partner, Head of Manager Selection & Development

    Paul Sargen

    Paul Sargen

    Partner, Chief Risk Officer

    Rebecca Benedict

    Rebecca Benedict

    Partner, Consultant Relations, Investor Relations & Business Development

    Scott Black

    Scott Black

    Partner, Chief Legal Officer & Chief Compliance Officer

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    8 investments
    CompanyRoundAmountDate
    LLocus Fermentation Solutions (Locus FS)Growth$20MDec 2025
    Humane logoHumaneSeries C$100MMar 2023
    Humane Inc. logoHumane Inc.Series C$100MJan 2023
    RemeGen logoRemeGenGrowth$100MApr 2020
    AAlphamab OncologySeries B$60MMay 2019
    SScivita MedicalSeries B
    荣昌生物 logo荣昌生物Unknown$100M
    Eos Energy logoEos EnergyUnknown$75M

    Top Co-Investors

    Last updated: 8 September 2026